A detailed history of Wells Fargo & Company transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Wells Fargo & Company holds 28,393 shares of BPMC stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,393
Previous 25,952 9.41%
Holding current value
$2.61 Million
Previous $2.46 Million 24.34%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$85.18 - $108.78 $207,924 - $265,531
2,441 Added 9.41%
28,393 $3.06 Million
Q1 2024

May 10, 2024

BUY
$73.17 - $99.79 $95,413 - $130,126
1,304 Added 5.29%
25,952 $2.46 Million
Q4 2023

Feb 09, 2024

SELL
$43.96 - $92.84 $1.24 Million - $2.62 Million
-28,270 Reduced 53.42%
24,648 $2.27 Million
Q3 2023

Nov 13, 2023

SELL
$46.9 - $66.0 $143,560 - $202,026
-3,061 Reduced 5.47%
52,918 $2.66 Million
Q2 2023

Aug 15, 2023

BUY
$42.2 - $66.37 $456,646 - $718,189
10,821 Added 23.96%
55,979 $3.54 Million
Q1 2023

May 12, 2023

BUY
$37.97 - $50.0 $1.37 Million - $1.8 Million
36,089 Added 397.94%
45,158 $2.03 Million
Q4 2022

Feb 13, 2023

SELL
$41.06 - $66.48 $19,667 - $31,843
-479 Reduced 5.02%
9,069 $397,000
Q3 2022

Nov 14, 2022

SELL
$49.93 - $77.7 $28,460 - $44,289
-570 Reduced 5.63%
9,548 $629,000
Q2 2022

Aug 12, 2022

SELL
$45.23 - $70.15 $1.44 Million - $2.23 Million
-31,751 Reduced 75.83%
10,118 $511,000
Q1 2022

May 16, 2022

SELL
$54.1 - $110.08 $1.25 Million - $2.54 Million
-23,059 Reduced 35.51%
41,869 $2.68 Million
Q4 2021

Feb 14, 2022

SELL
$94.25 - $115.99 $1.72 Million - $2.12 Million
-18,248 Reduced 21.94%
64,928 $6.95 Million
Q3 2021

Nov 15, 2021

BUY
$80.98 - $109.47 $134,831 - $182,267
1,665 Added 2.04%
83,176 $8.55 Million
Q2 2021

Aug 16, 2021

SELL
$82.78 - $101.0 $914,222 - $1.12 Million
-11,044 Reduced 11.93%
81,511 $7.17 Million
Q1 2021

May 13, 2021

BUY
$90.71 - $108.28 $2.78 Million - $3.32 Million
30,684 Added 49.59%
92,555 $9 Million
Q4 2020

Feb 09, 2021

BUY
$92.08 - $124.48 $1.64 Million - $2.21 Million
17,769 Added 40.29%
61,871 $6.94 Million
Q3 2020

Nov 05, 2020

SELL
$66.45 - $92.7 $690,947 - $963,894
-10,398 Reduced 19.08%
44,102 $4.09 Million
Q2 2020

Aug 13, 2020

BUY
$57.09 - $79.27 $544,924 - $756,632
9,545 Added 21.23%
54,500 $4.25 Million
Q1 2020

May 14, 2020

BUY
$48.11 - $82.22 $2.16 Million - $3.7 Million
44,955 New
44,955 $2.63 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.49B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.